Sort   by:  
 Page size 
UnknownBeneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemia.
Not available
S-EPMC9796151 | biostudies-literature
UnknownOne-year mortality after ICU admission due to COVID-19 infection.
Not available
S-EPMC8764887 | biostudies-literature
UnknownIdentification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study.
Not available
S-EPMC7906623 | biostudies-literature
UnknownThe Cantabria Cohort, a protocol for a population-based cohort in northern Spain.
Not available
S-EPMC10698930 | biostudies-literature
UnknownA presumed mouse parvovirus with overlooked high toxicity for human primitive CD34<sup>+</sup> hematopoietic precursors <i>in vitro</i> and in bone marrow-humanized mice.
Not available
S-EPMC12671093 | biostudies-literature
UnknownShaping current European mitochondrial haplogroup frequency in response to infection: the case of SARS-CoV-2 severity.
Not available
S-EPMC11718132 | biostudies-literature
UnknownPrevalence of depression in patients with type 2 diabetes mellitus in Spain (the DIADEMA Study) : results from the MADIABETES cohort.
Not available
S-EPMC6157517 | biostudies-literature
UnknownMajor candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study.
Not available
S-EPMC9211796 | biostudies-literature
UnknownProcalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients.
Not available
S-EPMC10425511 | biostudies-literature
UnknownClustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort.
Not available
S-EPMC10958830 | biostudies-literature
Sort   by:  
 Page size